Hong‐Qing Cai

1.1k total citations
33 papers, 665 citations indexed

About

Hong‐Qing Cai is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Hong‐Qing Cai has authored 33 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Genetics and 13 papers in Cancer Research. Recurrent topics in Hong‐Qing Cai's work include Glioma Diagnosis and Treatment (14 papers), Ferroptosis and cancer prognosis (8 papers) and MicroRNA in disease regulation (4 papers). Hong‐Qing Cai is often cited by papers focused on Glioma Diagnosis and Treatment (14 papers), Ferroptosis and cancer prognosis (8 papers) and MicroRNA in disease regulation (4 papers). Hong‐Qing Cai collaborates with scholars based in China and United States. Hong‐Qing Cai's co-authors include Jinghai Wan, Ming‐Rong Wang, Jia‐Jie Hao, Pengfei Wang, Meng Chen, Feng Zhang, Panpan Zhan, Jin Zhang, Shouwei Li and Changxiang Yan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Experimental Cell Research and Journal of Clinical Pathology.

In The Last Decade

Hong‐Qing Cai

32 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Qing Cai China 14 383 207 206 152 146 33 665
Changbin Zhu China 14 298 0.8× 179 0.9× 174 0.8× 88 0.6× 126 0.9× 40 676
Chen Zhu China 16 343 0.9× 180 0.9× 208 1.0× 100 0.7× 239 1.6× 35 680
Juan M. Funes United Kingdom 10 447 1.2× 198 1.0× 196 1.0× 87 0.6× 109 0.7× 15 686
Mohamad A. Salkeni United States 11 317 0.8× 237 1.1× 140 0.7× 76 0.5× 99 0.7× 42 603
Xiangdong Zhao China 14 324 0.8× 210 1.0× 196 1.0× 72 0.5× 47 0.3× 24 580
Hai Yu China 16 565 1.5× 162 0.8× 446 2.2× 67 0.4× 105 0.7× 31 792
Julie Godet France 16 253 0.7× 196 0.9× 163 0.8× 82 0.5× 161 1.1× 26 563
Yolanda Ruano Spain 13 314 0.8× 147 0.7× 147 0.7× 270 1.8× 111 0.8× 40 712
Hecheng Zhu China 14 295 0.8× 110 0.5× 157 0.8× 54 0.4× 96 0.7× 29 530

Countries citing papers authored by Hong‐Qing Cai

Since Specialization
Citations

This map shows the geographic impact of Hong‐Qing Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Qing Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Qing Cai more than expected).

Fields of papers citing papers by Hong‐Qing Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Qing Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Qing Cai. The network helps show where Hong‐Qing Cai may publish in the future.

Co-authorship network of co-authors of Hong‐Qing Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Qing Cai. A scholar is included among the top collaborators of Hong‐Qing Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Qing Cai. Hong‐Qing Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Jing, et al.. (2025). Clinical feasibility of AI Doctors: Evaluating the replacement potential of large language models in outpatient settings for central nervous system tumors. International Journal of Medical Informatics. 203. 106013–106013. 1 indexed citations
2.
Wan, Jinghai, et al.. (2025). Regulatory mechanisms of O6-methylguanine methyltransferase expression in glioma cells. Science Progress. 108(2). 352315510–352315510.
3.
Hao, Jia‐Jie, Na Zhang, Hong‐Qing Cai, et al.. (2024). Nuclear-cytoplasmic translocation of SQSTM1/p62 protein enhances ESCC cell migration and invasion by stabilizing EPLIN expression. Experimental Cell Research. 435(1). 113910–113910. 4 indexed citations
4.
5.
Wang, Xin, Hua Bai, Jiyang Zhang, et al.. (2023). Genetic Intratumor Heterogeneity Remodels the Immune Microenvironment and Induces Immune Evasion in Brain Metastasis of Lung Cancer. Journal of Thoracic Oncology. 19(2). 252–272. 16 indexed citations
6.
Guo, Jing, Liyan Yang, Hong‐Qing Cai, et al.. (2022). Dysregulation of CXCL14 promotes malignant phenotypes of esophageal squamous carcinoma cells via regulating SRC and EGFR signaling. Biochemical and Biophysical Research Communications. 609. 75–83. 8 indexed citations
7.
Yuan, Qing, et al.. (2022). Identifying Differential Expression Genes and Prognostic Signature Based on Subventricular Zone Involved Glioblastoma. Frontiers in Genetics. 13. 912227–912227. 7 indexed citations
8.
Zhang, Tong-Tong, Yiqing Zhu, Hong‐Qing Cai, et al.. (2022). Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC. Translational Oncology. 28. 101609–101609. 3 indexed citations
9.
10.
Wan, Li, Hong‐Qing Cai, Liwen Ren, et al.. (2022). Sphingosine kinase 1 promotes growth of glioblastoma by increasing inflammation mediated by the NF-κB /IL-6/STAT3 and JNK/PTX3 pathways. Acta Pharmaceutica Sinica B. 12(12). 4390–4406. 34 indexed citations
11.
Yuan, Qing, et al.. (2022). Preoperative blood testing for glioblastoma, brain metastases, and primary central nervous system lymphoma differentiation. Translational Cancer Research. 11(1). 63–71. 6 indexed citations
12.
Yu, Jing, Tingting Liu, Leilei Liang, et al.. (2021). Identification and validation of a novel glycolysis-related gene signature for predicting the prognosis in ovarian cancer. Cancer Cell International. 21(1). 353–353. 21 indexed citations
13.
Han, Song, Pengfei Wang, Hong‐Qing Cai, et al.. (2021). Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas. Aging. 13(11). 15444–15458. 19 indexed citations
14.
Cai, Hong‐Qing, Minjie Zhang, Zhijian Cheng, et al.. (2021). FKBP10 promotes proliferation of glioma cells via activating AKT-CREB-PCNA axis. Journal of Biomedical Science. 28(1). 13–13. 35 indexed citations
15.
16.
Cai, Hong‐Qing, Zhijian Cheng, Haipeng Zhang, et al.. (2018). Overexpression of MCM6 predicts poor survival in patients with glioma. Human Pathology. 78. 182–187. 35 indexed citations
17.
Ma, Sai, Chenchen Lü, Liyan Yang, et al.. (2018). ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis. Journal of Experimental & Clinical Cancer Research. 37(1). 183–183. 90 indexed citations
18.
Zhang, Jin, Hong‐Qing Cai, Panpan Zhan, et al.. (2018). LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients. Journal of Experimental & Clinical Cancer Research. 37(1). 225–225. 147 indexed citations
19.
Wang, Pengfei, Hong‐Qing Cai, Lingwei Kong, et al.. (2017). Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival. Oncotarget. 8(30). 50117–50123. 82 indexed citations
20.
He, Jie, et al.. (2017). Dumbbell-Shaped Jugular Foramen Tumors Extending to the Neck: Surgical Considerations Based on Imaging Findings. World Neurosurgery. 104. 14–23. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changbin Zhu Breakdown of academic impact, for papers by Chen Zhu Breakdown of academic impact, for papers by Juan M. Funes Breakdown of academic impact, for papers by Mohamad A. Salkeni Breakdown of academic impact, for papers by Xiangdong Zhao Breakdown of academic impact, for papers by Hai Yu Breakdown of academic impact, for papers by Julie Godet Breakdown of academic impact, for papers by Yolanda Ruano Breakdown of academic impact, for papers by Hecheng Zhu
Rankless by CCL
2026